Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Pharmaceutical Development and Technology|June 18, 2002
A novel method for removing residual acetone from gelatin microspheresWei Wang, Kris Antonsen, Rajiv NayarEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 27, 2009
Impact of bulking agents on the stability of a lyophilized monoclonal antibodyJeffrey D Meyer, Rajiv Nayar, Mark Cornell ManningJournal of Pharmaceutical Sciences|July 30, 2005
Noninvasive determination of protein conformation in the solid state using near infrared (NIR) spectroscopyShujun Bai, Rajiv Nayar, John F Carpenter, et al.Journal of Pharmaceutical Sciences|April 11, 2008
Effect of pH on stability of recombinant botulinum serotype A vaccine in aqueous solution and during storage of freeze-dried formulationsShouvik Roy, Ian Henderson, Rajiv Nayar, et al.Journal of Pharmaceutical Sciences|May 24, 2007
Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvantsChristina Vessely, Tia Estey, Theodore W Randolph, et al.Journal of Pharmaceutical Sciences|September 7, 2004
Quantification of glycine crystallinity by near-infrared (NIR) spectroscopyShu Jun Bai, Meena Rani, Raj Suryanarayanan, et al.Journal of Pharmaceutical Sciences|September 11, 2008
Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometryTia Estey, Christina Vessely, Theodore W Randolph, et al.Clinical and Experimental Pharmacology & Physiology|August 2, 2008
Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in miceKathleen A Stringer, Meghan Tobias, John S Dunn, et al.Journal of Pharmaceutical Sciences|April 7, 2004
Infrared spectroscopic studies of protein formulations containing glycineJeffrey D Meyer, Shu Jun Bai, Meena Rani, et al.Pulmonary Pharmacology & Therapeutics|November 3, 2009
Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in miceNicholas P Lackowski, Josh E Pitzer, Meghan Tobias, et al.Pageof 2